搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
ENDPOINTS NEWS
2 天
Viatris' India-based manufacturing site blocked from shipping 11 generic ...
Generic drug firm Viatris announced Monday that one of its India-based manufacturing facilities has been placed on import ...
ENDPOINTS NEWS
1 天
Three drugmakers sue US over 340B discounts to STD clinics they allege don’t ...
Amgen, Eli Lilly and UCB sued the federal government, claiming that several STD clinics getting drug discounts under the ...
ENDPOINTS NEWS
1 天
Federal appeals court says Teva must delist Orange Book inhaler patents
The Federal Trade Commission is praising an appeals court decision calling for Teva to delist five inhaler patents from the ...
ENDPOINTS NEWS
2 天
Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warn ...
The FDA on Friday issued two simultaneous cystic fibrosis approvals for Vertex Pharmaceuticals, but included boxed safety ...
ENDPOINTS NEWS
1 天
CagriSema’s weight loss data disappointed. What does Novo do next?
Novo Nordisk's CagriSema fell short of weight loss goals, causing 17% stock drop. Drug shows similar results to Eli Lilly's ...
ENDPOINTS NEWS
1 天
CMS explains what went into its first round of drug price negotiations
The Centers for Medicare and Medicaid Services on Friday released detailed but heavily redacted explanations of how it ...
ENDPOINTS NEWS
2 天
Novo Nordisk’s once-daily hemophilia drug Alhemo approved in US
FDA approves Novo Nordisk's Alhemo for hemophilia A and B with inhibitors. Once-daily shot reduces bleeding episodes in ...
ENDPOINTS NEWS
5 天
The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma
Eli Lilly dominates obesity market, megadeals decline, I&I sector thrives, and FDA's setback in misinformation fight.
ENDPOINTS NEWS
2 天
Jim Wilson's GemmaBio raises $34M to commercialize gene therapies for rare ...
GemmaBio, a company founded by gene therapy pioneer Jim Wilson, has raised $34 million in seed funding to try and resuscitate ...
ENDPOINTS NEWS
2 天
Bristol Myers' TYK2 inhibitor succeeds in pair of Phase 3 psoriatic arthri ...
Bristol Myers Squibb's Sotyktu succeeds in Phase 3 psoriatic arthritis trials, as company leads TYK2 race against Takeda & ...
ENDPOINTS NEWS
2 天
Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital ...
An affiliate of Deerfield Management Company will acquire Singular Genomics Systems, ending a months-long competition between ...
ENDPOINTS NEWS
2 天
Sumitomo’s overactive bladder drug adds another indication
Sumitomo Pharma’s oral treatment for overactive bladder symptoms has won an expanded label from the FDA, and is now approved ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈